G6pdN126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease
J Am Heart Assoc. 2024 Sep 18:e035174. doi: 10.1161/JAHA.123.035174. Online ahead of print. ABSTRACT BACKGROUND: G6PD (glucose-6-phosphate-dehydrogenase) is a key enzyme in the glycolytic pathway …